DIFFERENCES IN TREATMENT OUTCOMES AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH AND WITHOUT COMORBID SUBSTANCE ABUSE

被引：0
作者：
Greene, M. [1 ]
Yan, T. [2 ]
Chang, E. [2 ]
Hartry, A. [3 ]
Yermilov, I [2 ]
Broder, M. S. [2 ]
机构：
[1] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[2] Partnership Hlth Analyt Res LLC, Beverly Hills, CA USA
[3] Lundbeck, Deerfield, IL USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH30
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [21] Learning and Memory Differences among Women with and without Major Depressive Disorder (MDD)
    Walker, Sara J.
    Kassel, Michelle T.
    Weisenbach, Sara L.
    Pecina, Marta
    Considine, Ciaran M.
    Giordani, Bruno
    Noll, Douglas C.
    Zubieta, Jon-Kar
    Langenecker, Scott A.
    [J]. BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 254S - 254S
  • [22] In Hospital Outcomes of MRSA Septicemia Among Patients with and Without Substance Abuse
    Ahmad, B.
    Ogunti, R.
    Cousins, K.
    Munawar, M. M.
    Ganta, N.
    Larbi, D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [23] Comorbid conditions and medication utilization among patients with major depressive disorder in the United States
    Shah, Ankita
    Bloomgren, Gary
    O'Sullivan, Amy
    Wenten, Made
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 155 - 155
  • [24] Functional Impairment in Patients With Major Depressive Disorder and Comorbid Anxiety Disorder
    Gili, Margalida
    Garcia Toro, Mauro
    Armengol, Silvia
    Garcia-Campayo, Javier
    Castro, Adoracion
    Roca, Miquel
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2013, 58 (12): : 679 - 686
  • [25] Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder
    Vega, Charles
    Becker, Russell V.
    Mucha, Lisa
    Lorenz, Betty H.
    Eaddy, Michael T.
    Ogbonnaya, Augustina O.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (10) : 1879 - 1889
  • [26] Clozapine treatment of comorbid substance abuse in patients with schizophrenia
    Buckley, P
    McCarthy, M
    Chapman, P
    Richman, C
    Yamamoto, B
    [J]. SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 272 - 272
  • [27] Socioeconomic Predictors of Treatment Outcomes Among Adults With Major Depressive Disorder
    Cohen, Alex
    [J]. PSYCHIATRIC SERVICES, 2023, 74 (02) : 214 - 215
  • [28] Heterogeneity in Antidepressant Treatment and Major Depressive Disorder Outcomes Among Clinicians
    Rathnam, Sarah
    Hart, Kamber L.
    Sharma, Abhishek
    Verhaak, Pilar F.
    McCoy, Thomas H.
    Doshi-Velez, Finale
    Perlis, Roy H.
    [J]. JAMA PSYCHIATRY, 2024, 81 (10) : 1003 - 1009
  • [29] Socioeconomic Predictors of Treatment Outcomes Among Adults With Major Depressive Disorder
    Mills, Jeffrey A.
    Suresh, Vikram
    Chang, Lenisa
    Mayes, Taryn
    Croarkin, Paul E.
    Trivedi, Madhukar H.
    Strawn, Jeffrey R.
    [J]. PSYCHIATRIC SERVICES, 2022, 73 (09) : 965 - 969
  • [30] Baclofen Abuse due to Its Hypomanic Effect in Patients with Alcohol Dependence and Comorbid Major Depressive Disorder
    Ghosh, Soumitra
    Bhuyan, Dhrubajyoti
    [J]. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2017, 15 (02) : 187 - 189
12345